Skip Navigation


Annals of Oncology Advance Access originally published online on February 14, 2008
Annals of Oncology 2008 19(4):631-640; doi:10.1093/annonc/mdm597
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/4/631    most recent
mdm597v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bosetti, C.
Right arrow Articles by La Vecchia, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosetti, C.
Right arrow Articles by La Vecchia, C.
Related Collections
Right arrow 2008 - Editors Choice
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

epidemiology

Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis

C. Bosetti1,*, P. Bertuccio1, F. Levi2, F. Lucchini2, E. Negri1 and C. La Vecchia1,3

1 Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy
2 Unité d'épidémiologie du cancer et Registres vaudois et neuchâtelois des tumeurs, Institut de médecine sociale et préventive, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland
3 Istituto di Statistica Medica e Biometria ‘G. A. Maccacaro’, Università degli Studi di Milano, Milan, Italy

* Correspondence to: Dr C. Bosetti, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Lamasa 19, 20156 Milan, Italy. Tel: +39-02-39014-526; Fax: +39-02-33200231; E-mail: bosetti{at}marionegri.it

Background: Cancer mortality peaked in the European Union (EU) in the late 1980s and declined thereafter.

Materials and methods: We analyzed EU cancer mortality data provided by the World Health Organization in 1970–2003, using joinpoint analysis.

Results: Overall, cancer mortality levelled off in men since 1988 and declined in 1993–2003 (annual percent change, APC = –1.3%). In women, a steady decline has been observed since the early 1970s. The decline in male cancer mortality has been driven by lung cancer, which levelled off since the late 1980s and declined thereafter (APC = 2.7% in 1997–2003). Recent decreases were also observed for other tobacco-related cancers, as oral cavity/pharynx, esophagus, larynx and bladder, as well as for colorectal (APC = –0.9% in 1992–2003) and prostate cancers (APC = –1.0% in 1994–2003). In women, breast cancer mortality levelled off since the early 1990s and declined thereafter (APC = –1.0% in 1998–2003). Female mortality declined through the period 1970–2003 for colorectal and uterine cancer, while it increased over the last three decades for lung cancer (APC = 4.6% in 2001–2003). In both sexes, mortality declined in 1970–2003 for stomach cancer and for a few cancers amenable to treatment.

Conclusion: This update analysis of the mortality from cancer in the EU shows favorable patterns over recent years in both sexes.

Key words: cancer, European Union, mortality, trends

Received for publication October 25, 2007. Revision received November 26, 2007. Accepted for publication December 14, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
P. Boyle
Favorable trends in cancer mortality in the European Union but no room for complacency
Ann. Onc., April 1, 2008; 19(4): 605 - 606.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.